Evonik Industries AG (EVKIY) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EVKIY representa a Evonik Industries AG, una empresa del sector Basic Materials con un precio de $ (capitalización de mercado 0). Calificado con 39/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Evonik Industries AG (EVKIY) Exposición a Materiales y Productos Básicos
Evonik Industries AG, a German-based specialty chemicals company, operates across diverse segments, providing additives, nutrition, smart materials, and performance materials. With a global presence and a focus on innovation, Evonik serves industries ranging from automotive and construction to consumer goods and healthcare, leveraging its broad product portfolio and established market position.
Tesis de Inversión
Evonik Industries AG presents a mixed investment thesis. The company's diverse portfolio of specialty chemicals provides stability across various end markets. The dividend yield of 8.15% may attract income-focused investors. However, a profit margin of 1.9% indicates potential challenges in profitability. Future growth will depend on Evonik's ability to innovate in high-margin specialty chemicals and capitalize on growing demand in sectors like automotive and healthcare. Investors should monitor the company's ability to improve profitability and manage operational costs. The P/E ratio of 25.25 suggests the stock may be fairly valued.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $7.59 billion reflects Evonik's significant presence in the specialty chemicals market.
- Dividend yield of 8.15% offers an attractive income stream for investors.
- Profit margin of 1.9% indicates potential areas for improvement in operational efficiency.
- Gross margin of 23.1% demonstrates the value-added nature of Evonik's specialty chemical products.
- Beta of 0.74 suggests lower volatility compared to the broader market.
Competidores y Pares
Fortalezas
- Diverse product portfolio across multiple segments.
- Global presence with operations in key regions.
- Strong focus on innovation and research and development.
- Established relationships with major customers in various industries.
Debilidades
- Relatively low profit margin compared to some competitors.
- Exposure to cyclical industries such as automotive and construction.
- Dependence on raw material prices and availability.
- Complexity of managing a large and diverse organization.
Catalizadores
- Ongoing: Expansion in the Asia-Pacific region, driven by increasing demand for specialty chemicals.
- Ongoing: Innovation in sustainable and bio-based chemicals, aligning with environmental awareness.
- Ongoing: Leveraging digital technologies to optimize operations and enhance customer engagement.
- Upcoming: Potential strategic acquisitions and partnerships to expand product portfolio and geographic reach.
- Ongoing: Increasing demand for specialty chemicals in the healthcare sector.
Riesgos
- Ongoing: Intense competition from other specialty chemical companies.
- Potential: Economic downturns and fluctuations in demand.
- Potential: Regulatory changes and environmental concerns.
- Potential: Disruptions in supply chains and raw material availability.
- Ongoing: Currency risk associated with the ADR structure.
Oportunidades de crecimiento
- Growth Opportunity 1: Expansion in the Asia-Pacific region represents a significant growth opportunity for Evonik. The increasing demand for specialty chemicals in countries like China and India, driven by growing industrialization and urbanization, offers substantial market potential. Evonik can leverage its existing presence and invest in new facilities and partnerships to capitalize on this growth, targeting specific sectors like automotive and construction. This expansion could contribute significantly to revenue growth over the next 3-5 years.
- Growth Opportunity 2: Innovation in sustainable and bio-based chemicals aligns with increasing environmental awareness and regulatory pressures. Evonik can invest in research and development to create new products and solutions that meet the growing demand for sustainable alternatives. This includes developing bio-based polymers, biodegradable additives, and environmentally friendly coatings. This focus on sustainability can differentiate Evonik from competitors and attract environmentally conscious customers, driving long-term growth.
- Growth Opportunity 3: Leveraging digital technologies to optimize operations and enhance customer engagement presents a significant opportunity. Evonik can invest in digital platforms to improve supply chain management, streamline manufacturing processes, and provide customized solutions to customers. This includes using data analytics to optimize product formulations and predict customer needs. Digitalization can improve efficiency, reduce costs, and enhance customer satisfaction, driving revenue growth and profitability.
- Growth Opportunity 4: Strategic acquisitions and partnerships can expand Evonik's product portfolio and geographic reach. Evonik can target companies with complementary technologies and market access to strengthen its position in key segments. This includes acquiring companies specializing in high-growth areas like advanced materials and specialty additives. Strategic partnerships can also provide access to new markets and technologies, accelerating growth and innovation.
- Growth Opportunity 5: Increasing demand for specialty chemicals in the healthcare sector offers a promising growth avenue. Evonik can leverage its expertise in pharmaceutical polymers, amino acids, and other ingredients to develop innovative solutions for drug delivery, medical devices, and nutritional supplements. This includes developing customized formulations and providing technical support to pharmaceutical and healthcare companies. The aging global population and increasing healthcare spending are driving demand in this sector, creating significant growth opportunities for Evonik.
Oportunidades
- Expansion in emerging markets with high growth potential.
- Increasing demand for sustainable and bio-based chemicals.
- Leveraging digital technologies to improve efficiency and customer engagement.
- Strategic acquisitions and partnerships to expand product portfolio and market reach.
Amenazas
- Intense competition from other specialty chemical companies.
- Economic downturns and fluctuations in demand.
- Regulatory changes and environmental concerns.
- Disruptions in supply chains and raw material availability.
Ventajas competitivas
- Specialty chemicals expertise: Evonik's extensive knowledge and experience in specialty chemicals provide a competitive advantage.
- Diverse product portfolio: The company's broad range of products and solutions caters to various industries, reducing dependence on any single market.
- Global presence: Evonik's operations in multiple regions provide access to diverse markets and customer bases.
- Strong customer relationships: The company's focus on customized solutions and technical support fosters long-term customer relationships.
Acerca de EVKIY
Founded in 1873 and headquartered in Essen, Germany, Evonik Industries AG has evolved into a leading specialty chemicals company. Originally rooted in coal and steel, the company transitioned to specialty chemicals, focusing on high-value products and solutions. Evonik operates through five segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment offers products like polyurethane additives and fumed silicas. The Nutrition & Care segment provides ingredients for consumer goods, animal nutrition, and healthcare. The Smart Materials segment delivers advanced materials for automotive and construction. The Performance Materials segment produces polymer materials and intermediates. The Technology & Infrastructure segment offers site management and engineering services. Evonik serves a global customer base across Asia-Pacific, Europe, the Middle East, Africa, and the Americas. As a subsidiary of RAG-Stiftung, Evonik continues to innovate and expand its portfolio of specialty chemical solutions.
Qué hacen
- Develops and manufactures specialty additives for various industries.
- Produces nutrition and care products for consumer goods, animal nutrition, and healthcare.
- Offers smart materials for automotive, paints, coatings, adhesives, and construction sectors.
- Manufactures performance materials and intermediates for rubber, plastics, and automotive industries.
- Provides technology and infrastructure services, including site management and engineering.
- Supplies hydrogen peroxide and peracetic acid for various applications.
Modelo de Negocio
- Evonik generates revenue by selling specialty chemicals and materials to a diverse range of industries.
- The company focuses on high-value-added products and customized solutions to meet specific customer needs.
- Evonik operates through five segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure.
- The company invests in research and development to innovate new products and improve existing ones.
Contexto de la Industria
Evonik operates in the specialty chemicals industry, which is characterized by high value-added products and customized solutions. The industry is driven by innovation, sustainability, and increasing demand from end markets like automotive, construction, and healthcare. Competition is intense, with companies like ASGLY and BNTGF vying for market share. Market trends include a focus on sustainable and bio-based chemicals, as well as digitalization and automation in manufacturing processes. The global specialty chemicals market is expected to grow, driven by increasing demand from emerging economies and technological advancements.
Clientes Clave
- Automotive industry: Provides materials for vehicle manufacturing and coatings.
- Construction industry: Supplies additives for concrete, adhesives, and sealants.
- Consumer goods industry: Offers ingredients for personal care products and detergents.
- Healthcare industry: Provides pharmaceutical polymers and amino acids for drug delivery and nutrition.
Finanzas
Gráfico e información
Precio de la acción de Evonik Industries AG (EVKIY): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para EVKIY.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para EVKIY.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para EVKIY.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de EVKIY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Christian Kullmann
Chairman of the Executive Board
Christian Kullmann has been Chairman of the Executive Board of Evonik Industries AG since 2017. He previously held various leadership positions within the company, including Chief Strategic Officer and Head of the Advanced Intermediates Business Unit. Kullmann holds a degree in business administration from the University of Münster and has extensive experience in the chemical industry.
Historial: Under Kullmann's leadership, Evonik has focused on strengthening its position in specialty chemicals and driving innovation. He has overseen strategic acquisitions and partnerships to expand the company's product portfolio and geographic reach. Kullmann has also emphasized sustainability and digitalization as key drivers of future growth.
Información de ADR de Evonik Industries AG No patrocinado
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. EVKIY is an ADR representing shares of Evonik Industries AG. This allows U.S. investors to invest in Evonik without directly dealing with foreign exchanges.
- Ticker del mercado local: Essen, DE
- Nivel de ADR: 1
- Ratio de ADR: 1:1
- Ticker del mercado local: EVKI
Información del mercado OTC de EVKIY
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure, may not meet minimum listing standards, and may be subject to higher risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires extra caution and due diligence.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases the risk of investing in EVKIY.
- Lower trading volume and wider bid-ask spreads can lead to price volatility and illiquidity.
- OTC stocks are subject to less regulatory oversight than exchange-listed stocks.
- The 'OTC Other' tier indicates a higher level of risk compared to other OTC tiers.
- Potential for fraud or manipulation is higher in the OTC market.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any news articles or reports that raise red flags.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC investing.
- Evonik Industries AG is a well-established company with a long history.
- The company operates in the specialty chemicals industry, which has significant barriers to entry.
- Evonik is a subsidiary of RAG-Stiftung, a reputable organization.
- The company has a global presence and serves a diverse range of industries.
Preguntas Comunes Sobre EVKIY
¿Cuáles son los factores clave para evaluar EVKIY?
Evonik Industries AG (EVKIY) actualmente tiene una puntuación IA de 39/100, indicando puntuación baja. Fortaleza clave: Diverse product portfolio across multiple segments.. Riesgo principal a monitorear: Ongoing: Intense competition from other specialty chemical companies.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de EVKIY?
EVKIY actualmente puntúa 39/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de EVKIY?
Los precios de EVKIY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre EVKIY?
La cobertura de analistas para EVKIY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en EVKIY?
Las categorías de riesgo para EVKIY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition from other specialty chemical companies.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de EVKIY?
La relación P/E para EVKIY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está EVKIY sobrevalorada o infravalorada?
Determinar si Evonik Industries AG (EVKIY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de EVKIY?
Evonik Industries AG (EVKIY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data and market information are based on available sources and may be subject to change.
- The analysis provided is for informational purposes only and should not be considered investment advice.
- OTC market data may be less reliable than exchange-listed data.